Company / R&D per Share
BioNexus Gene Lab Corp R&D per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.03
FY2025
5-year range
$0.00 / $0.03
FY2023-FY2025
Trend
+948.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share changed +949% YoY in FY2025, a notable deviation from the 2-year average annual change of +460%.
Based on SEC 10-K filings.
0.03 in FY2025.
Improved from $0.00 to $0.03 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 948.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.03 | +948.7% |
| FY2024 | $0.00 | -29.2% |
| FY2023 | $0.00 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026